Related Experiment Videos
Screening of selected pesticides for oestrogen receptor activation in vitro
A M Vinggaard1, V Breinholt, J C Larsen
1Institute of Food Safety and Toxicology, Danish Veterinary and Food Administration, Soborg, Denmark. amv@fdor.dk
Abstract:
Twenty pesticides were tested for their ability to activate the oestrogen receptor in vitro using an MCF7 cell proliferation assay and a Yeast Oestrogen Screen. The fungicides fenarimol, triadimefon, and triadimenol were identified as weak oestrogen receptor agonists, which at 10 microM induces a 2.0, 2.4, and 1.9-fold increase in proliferation of human MCF7 breast cancer cells (E3 clone). The relative proliferation efficiency (RPE) was 43-69%, indicating partial agonism at the oestrogen receptor. Several pesticides did not have any effect on the proliferation response after 6 days of exposure, including: chlorpyrifos, diuron, iprodion, linuron, pentachlorphenol, prochloraz, propioconazol, propyzamine, quintozen, tetrachorvinphos and tetradifon. Some pesticides resulted in a negligible proliferation response, which was not statistically significant under the present experimental conditions. These were: bromopropylate, chlorfenvinphos, chlorobenzilate, dicofol, heptachlor, and imazalil. Fenarimol and dicofol also gave rise to a positive oestrogenic response in yeast cells transfected with the oestrogen receptor alpha, whereas the remaining compounds resulted in a negative response due either to biological inactivity or cytotoxocity to the yeast cells. The EC50 for fenarimol was estimated to be 13 microM in the yeast cells, compared with an EC50 of 3 microM in the MCF7 cells, indicating higher sensitivity of the latter assay. No in vivo data for fenarimol, triadimefon or triadimenol have previously been published that support oestrogenic activity in the intact animal. Thus, from the present results we suggest that oestrogen receptor activation may not be an important mode of action for these compounds. The need to include at least two bioassays in a screening procedure and for combining in vitro and in vivo data is emphasized.
Insights
Three fungicides, fenarimol, triadimefon, and triadimenol, were identified as weak oestrogen receptor agonists in vitro. Further research is needed to confirm oestrogenic activity in vivo.
Area of Science:
- Environmental Toxicology
- Endocrinology
Background:
- Pesticide exposure is a growing concern for environmental and human health.
- The oestrogen receptor (ER) is a key target for endocrine-disrupting chemicals.
- In vitro assays are crucial for initial screening of potential ER agonists.
Purpose of the Study:
- To screen twenty pesticides for oestrogen receptor (ER) activation.
- To compare the sensitivity of two in vitro assays: MCF7 cell proliferation and Yeast Oestrogen Screen (YESS).
- To evaluate the potential endocrine-disrupting activity of selected pesticides.
Main Methods:
- Utilized MCF7 cell proliferation assay and Yeast Oestrogen Screen (YESS) for ER activation screening.
- Tested twenty different pesticides, including fungicides and insecticides.
- Determined relative proliferation efficiency (RPE) and EC50 values for active compounds.
Main Results:
- Fenarimol, triadimefon, and triadimenol showed weak ER agonism in MCF7 cells (2.0-2.4 fold increase).
- Fenarimol and dicofol exhibited positive oestrogenic response in the YESS assay.
- Several pesticides, including chlorpyrifos and diuron, showed no significant ER activation.
Conclusions:
- Fenarimol, triadimefon, and triadimenol are weak in vitro ER agonists.
- The MCF7 assay demonstrated higher sensitivity than the YESS assay for fenarimol.
- Current in vitro findings suggest ER activation may not be the primary mode of action for these compounds in vivo.